This HTML5 document contains 146 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q40647176
rdf:type
wikibase:Item
schema:description
επιστημονικό άρθρο tudományos cikk artigo científico scientific article published on August 1997 wissenschaftlicher Artikel บทความทางวิทยาศาสตร์ 1997年論文 научни чланак научни чланак мақолаи илмӣ 1997年の論文 مقالة علمية نشرت في أغسطس 1997 naučni članak 1997年论文 articol științific artigo científico scientific article published on August 1997 1997年論文 vědecký článek научная статья আগস্ট ১৯৯৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artykuł naukowy artikull shkencor scienca artikolo artículu científicu espublizáu en 1997 1997年论文 article científic наукова стаття, опублікована в серпні 1997 bilimsel makale 1997年论文 vitskapeleg artikkel artículo científico publicado en 1997 article scientific 1997年論文 1997年论文 artikel ilmiah artigo científico scientific article published on August 1997 article scientifique 1997年論文 מאמר מדעי vedecký článok articolo scientifico vetenskaplig artikel artikulong pang-agham vitenskapelig artikkel bài báo khoa học 1997年论文 1997 nî lūn-bûn სამეცნიერო სტატია 1997年论文 wetenschappelijk artikel 1997年論文 videnskabelig artikel научна статия teaduslik artikkel 1997년 논문 tieteellinen artikkeli
p:P577
wds:Q40647176-87234AF7-5E60-493D-B7F9-3FAAD69D3C2F
wdt:P577
1997-08-01T00:00:00Z
p:P2860
wds:Q40647176-79C7C27D-E941-4D1F-8D69-B1B689B53E09 wds:Q40647176-81CC3F58-F152-43D2-9600-6902230B3CC8 wds:Q40647176-5BAFBD64-6353-4912-A6F9-20F9DA03A2D6 wds:Q40647176-2CC081D6-4A37-4144-83D7-C1A72EFF0292 wds:Q40647176-34BACA2F-3804-407C-8970-6F3FD21048ED wds:Q40647176-34BCAD03-6E5E-4430-B732-8BAF053F8544 wds:Q40647176-369556A5-C5A7-475F-801E-1E90E415A70D wds:Q40647176-C84C2F46-5C88-4A0E-951D-3BD22D1A71D1 wds:Q40647176-D18A5204-62A3-4EFE-9D17-83ADB0E8182F wds:Q40647176-A9539DF0-C874-4B5C-9330-28AD0D35B7CF wds:Q40647176-ACC0E67F-B528-4FF7-A23E-74812479612C wds:Q40647176-B26AA55B-6264-4B3A-9E5F-DD84040952A4 wds:Q40647176-91731917-34CA-4F5C-A78F-4248B9B389EE wds:Q40647176-9BA81372-E6D5-44FC-8911-F4619CE11866 wds:Q40647176-A11C3FE9-4F17-411C-B5DD-31AFBA17A124 wds:Q40647176-8DA1CA85-7FF1-4992-B48B-9EE6BA66BD3E wds:Q40647176-8E6544C9-2138-4912-A39A-4657B1F3A0C0 wds:Q40647176-E31EAF47-1B07-4D5E-9AB4-0FD33357786B wds:Q40647176-20803FF7-5BC7-4146-879B-F5CE7097A55E wds:Q40647176-2582C441-EDC8-4CE1-B916-D239F537BC07 wds:Q40647176-2646706F-1C4B-4DE0-A0F4-0ED79E5D2862 wds:Q40647176-2034C2FA-7C05-406D-9F29-E4A308E83CFE
wdt:P2860
wd:Q34560161 wd:Q36029532 wd:Q45740110 wd:Q69105467 wd:Q54655630 wd:Q29620070 wd:Q69870049 wd:Q46483666 wd:Q40746556 wd:Q35592216 wd:Q40695971 wd:Q72101991 wd:Q40725458 wd:Q72084069 wd:Q40785644 wd:Q72100903 wd:Q40707016 wd:Q54660163 wd:Q71683351 wd:Q40697302 wd:Q67666123 wd:Q71671695
p:P2093
wds:Q40647176-D7B2B3AD-B9A1-441C-883D-69CECBFDB974 wds:Q40647176-B62C502A-4404-494B-8585-F8994538561B wds:Q40647176-CDD2CB4F-EAF4-4A43-9CF2-3288043EFC14 wds:Q40647176-6BE99764-65B5-46D0-B72F-283B96AC71BC wds:Q40647176-6C58BDEC-6893-44A9-A9C5-9362971E0BD0 wds:Q40647176-8292D5B1-9A19-46CA-9714-C79AA76C9AFD
wdt:P2093
Bear MB Logan E Mason CM Nelson S Johnson S Andresen J
rdfs:label
Phase 1 safety trial of Filgrastim (r-metHuG-CSF) in non-neutropenic patients with severe community-acquired pneumonia
skos:prefLabel
Phase 1 safety trial of Filgrastim (r-metHuG-CSF) in non-neutropenic patients with severe community-acquired pneumonia
schema:name
Phase 1 safety trial of Filgrastim (r-metHuG-CSF) in non-neutropenic patients with severe community-acquired pneumonia
p:P50
wds:Q40647176-3A2CBD65-8D2F-4774-815C-0B325CB73BBD wds:Q40647176-6320264B-88E1-4457-BFB2-9B3B863DFE9B wds:Q40647176-27A7737D-8C07-4830-A6F3-732318BBA326
wdt:P50
wd:Q118697907 wd:Q118746844 wd:Q87264744
p:P1476
wds:Q40647176-FD53B674-9E3C-4702-BCA2-FA3B52086746
wdt:P1476
Phase 1 safety trial of Filgrastim (r-metHuG-CSF) in non-neutropenic patients with severe community-acquired pneumonia
p:P304
wds:Q40647176-1711387B-91AB-4DE0-83FB-B536223F4577
wdt:P304
387-394
p:P31
wds:Q40647176-A3E01DF4-F014-4180-B2B7-080083C82BCD
wdt:P31
wd:Q13442814
p:P921
wds:Q40647176-57EF5494-F960-44CB-8629-47F0571E1727
wdt:P921
wd:Q5452194
p:P698
wds:Q40647176-5CE50DB2-0221-43C3-A36B-2E4D946A65D9
wdtn:P698
n10:9327037
wdt:P698
9327037
p:P1433
wds:Q40647176-8C5D0997-5DDD-4895-9525-BE48CB0C960F
wdt:P1433
wd:Q2659932
p:P433
wds:Q40647176-8DCB0C97-FC44-49AC-BFF0-A2DE21B7D096
p:P478
wds:Q40647176-C6DC6C1E-6B51-4D5D-A827-853B9E2CB1AB
wdt:P433
7
wdt:P478
91
p:P356
wds:Q40647176-4F8BD1EC-C052-4BB4-9122-6CC2A9D608EF
wdtn:P356
n11:S0954-6111(97)90250-X
wdt:P356
10.1016/S0954-6111(97)90250-X